Skip to main content
. 2024 Dec 17;14(53):39700–39707. doi: 10.1039/d4ra07577c

Fig. 4. Bactericidal activity in vivo. (a) In vivo fluorescence images of MDR PA lung-infected mice at various time points post-intravenous injection of ICG@HMnO2 and ICG@HMnO2@NM. (b) Lung bacterial loads in mice post-treatment with saline (control), HMnO2@NM, PMB and PMB@ HMnO2@NM. (c) Giemsa staining results of lung tissue after treatment with saline (control), HMnO2@NM, PMB and PMB@HMnO2@NM. Scale bars: 20 μm. (d) H & E staining of lung tissue after treatment with saline (control), HMnO2@NM, PMB and PMB@HMnO2@NM. Scale bars: 20 μm. (e) Serum levels of IL-6 and TNF-α collected after treated with saline (control), HMnnO2@NM, PMB and PMB@HMnO2@NM. (f) Percentage survival of pneumonia mice treated with saline (control), HMnO2@NM, PMB and PMB@HMnO2@NM (n = 6, *p < 0.05, **p < 0.01, ***p < 0.001, n.s. means no significance. Data are expressed in mean ± SD).

Fig. 4